Breaking
[CLAVICULAR]Fitness influencer Clavicular says he started taking testosterone at 14, calls natural training 'a waste'[BAXTER COUNTY]Woman with severe mental problems sitting in jail cell waiting on treatment[MEDICAID]Democratic senator proposes expanding Medicaid to cover children[UNIQUEPHARMACEUTICAL]Allergy medication recalled over potentially ‘life-threatening’ cross-contamination[FRIENDS OF BIG BEAR VALLEY]Rescued Big Bear bald eagle Jackie is ‘stable,’ wildlife nonprofit says[CLAVICULAR]Fitness influencer Clavicular says he started taking testosterone at 14, calls natural training 'a waste'[BAXTER COUNTY]Woman with severe mental problems sitting in jail cell waiting on treatment[MEDICAID]Democratic senator proposes expanding Medicaid to cover children[UNIQUEPHARMACEUTICAL]Allergy medication recalled over potentially ‘life-threatening’ cross-contamination[FRIENDS OF BIG BEAR VALLEY]Rescued Big Bear bald eagle Jackie is ‘stable,’ wildlife nonprofit says

Genetics

1 stories

AllMYRIAD GENETICSUWMEDICINENATURE GENETICSSCRIBENATUREGENETICS
Benjamin Oakes, CEO of Scribe Therapeutics, presents the company's clinical pipeline during a biotech investor conference.
SCRIBE9h ago

Scribe aims for $96M IPO to fund lipid-lowering genetic meds

Scribe Therapeutics is moving forward with its plan to go public on the Nasdaq. The Bay Area biotechnology company revealed in a recent filing that it aims to raise approximately $96 million through an initial public off…

← BACK TO ALL SCIENCE NEWS